Subtype
Intermediate Bone Neoplasm
CI-CAN-00002919Explore in graph →
Non-malignant7 active trials3 evidence items
- NCIt
- C121926
Loading cancer entity…
Subtype
CI-CAN-00002919Explore in graph →
Clinical trials
22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06647901 | Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study | recruiting | Phase 1 / Phase 2 | 45 | Tang XiaodongOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT04255576 | Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone | unknown | Phase 1 / Phase 2 | 139 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | Oct 14, 2022 | clinicaltrials |
| NCT01564121 | Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa(Zometa) | terminated | Phase 1 / Phase 2 | 24 | Nantes University HospitalOTHER | 1 | Aug 30, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Oct 18, 2024source: clinicaltrials